
To help keep our community authentic, we're showing information about accounts on Linktree.
nantpac has been a member of Linktree for 2 years and joined in April 2024. The social media accounts linked to from nantpac are: • Facebook • Instagram Besides social media accounts, nantpac has populated their site with: • Camp Ronald McDonald for Good Times • Machine Learning Tool Predicts a Child’s Cisplatin-Induced Hearing Loss Risk • Annual Report to the Nation 2025 National Cancer Statistics • Federal cuts to National Institutes of Health could threaten medical progress • Biomarker Testing: Unlocking Personalized Treatments to Improve Patient Outcomes • 2025 CNCF Parent Conference • ANR 2025 – ADVANCES IN NEUROBLASTOMA RESEARCH MEETING • AACR Legislative Action Center • Welcome! You are invited to join a webinar: International Neuroblastoma Summit: Breaking Boundaries in Research - Session #4: CAR-T with Dr. Francesca Del Bufalo.. After registering, you will receive a confirmation email about joining the webinar. • Driving Standardization of Molecular Testing Guidelines in Pediatric Cancer • Trahan, Miller-Meeks, Grassley, Bennet Introduce Bipartisan Legislation to Expand Health Care Access For Children • International Neuroblastoma Summit Webinar Registration • NANT - Collaborating Labs • Dr Araz Marachelian, History of NANT & Current Trials • INV724 Earns FDA Rare Pediatric Disease, Orphan Drug Designations for Neuroblastoma • 20 Years of Neuroblastoma Research Progress • NANT Fall Newsletter 2024.pdf • Long Beach Legacy Triathlon 2024: Mrs. Megan Nelson - Long Beach Triathlon | Children's Hospital Los Angeles • CHLA Neuroblastoma Program • CNCF Parent Conference • Childhood Cancer STAR (Survivorship, Treatment, Access, Research) Act (Public Law No: 115-180) • Sophia's Buddies Supports NANT at Hermosa Beach Tri • NANT Summer 2024 Newsletter • Yael P. Mossé, MD | Children's Hospital of Philadelphia • Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results - Nature Medicine • Blood Product Administration During High Risk Neuroblastoma Therapy • Julie R. Park, MD • NANT - Donate • Evelyn’s Neuroblastoma Fight • The EVAN Foundation • Find Your Representative | house.gov • Cancer Research In Action - Leslie's Thriver Story - V Foundation • A well-meaning FDA policy is a threat to pediatric cancer treatment • NANT - Parent Advisory Committee • NANT Website • NANT - PAC Instagram • NANT - PAC Facebook